Hereditary tyrosinemia type 1 metabolites impair DNA excision repair pathways

被引:15
|
作者
van Dyk, E. [1 ]
Steenkamp, A. [1 ]
Koekemoer, G. [2 ]
Pretorius, P. J. [1 ]
机构
[1] North West Univ, Sch Phys & Chem Sci, Ctr Human Metabon, ZA-2520 Potchefstroom, South Africa
[2] North West Univ, Stat Consultat Serv, ZA-2520 Potchefstroom, South Africa
基金
新加坡国家研究基金会;
关键词
Hereditary tyrosinemia; Base excision repair; Nucleotide excision repair; Comet assay; COMET ASSAY; DAMAGE; FUMARYLACETOACETATE; HOGG1;
D O I
10.1016/j.bbrc.2010.09.002
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hereditary tyrosinemia type 1 is an autosomal recessive metabolic disorder, which is caused by a defective fumarylacetoacetate hydrolase enzyme, and consequently metabolites such as succinylacetone and p-hydroxyphenylpyruvate accumulate. We used a modified comet assay to determine the effect of these metabolites on base- and nucleotide excision repair pathways. Our results indicate that the metabolites affected the repair mechanisms differently, since the metabolites had a bigger detrimental effect on BER than on NER. (C) 2010 Elsevier Inc. All rights reserved.
引用
收藏
页码:32 / 36
页数:5
相关论文
共 50 条
  • [41] Fumarylacetoacetate inhibits the initial step of the base excision repair pathway: implication for the pathogenesis of tyrosinemia type I
    Bliksrud, Yngve T.
    Ellingsen, Amund
    Bjoras, Magnar
    JOURNAL OF INHERITED METABOLIC DISEASE, 2013, 36 (05) : 773 - 778
  • [42] Clinical, biochemical, and genetic analysis of a Korean neonate with hereditary tyrosinemia type 1
    Park, Hyung-Doo
    Lee, Dong Hwan
    Choi, Tae-Youn
    Lee, You Kyoung
    Kim, Jong-Won
    Ki, Chang-Seok
    Lee, Yong-Wha
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2009, 47 (08) : 930 - 933
  • [43] Ex vivo gene editing and cell therapy for hereditary tyrosinemia type 1
    Ates, Ilayda
    Stuart, Callie
    Rathbone, Tanner
    Barzi, Mercedes
    He, Gordon
    Major, Angela M.
    Shankar, Vijay
    Lyman, Rachel A.
    Angner, Sidney S.
    Mackay, Trudy F. C.
    Srinivasan, Shanthi
    Farris, Alton Brad
    Bissig, Karl-Dimiter
    Cottle, Renee N.
    HEPATOLOGY COMMUNICATIONS, 2024, 8 (05)
  • [44] In vivo suppressor mutations correct a murine model of hereditary tyrosinemia type 1
    Labie, D
    M S-MEDECINE SCIENCES, 2000, 16 (03): : 419 - 420
  • [45] The XPA-binding domain of ERCC1 Is Required for Nucleotide Excision Repair but Not Other DNA Repair Pathways
    Orelli, Barbara
    McClendon, T. Brooke
    Tsodikov, Oleg V.
    Ellenberger, Tom
    Niedernhofer, Laura J.
    Schaerer, Orlando D.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (06) : 3705 - 3712
  • [46] Evaluation of dynamic thiol/disulfide homeostasis in hereditary tyrosinemia type 1 patients
    Ayse Cigdem Aktuglu Zeybek
    Ertugrul Kiykim
    Salim Neselioglu
    Halise Zeynep Iscan
    Tanyel Zubarioglu
    Mehmet Serif Cansever
    Ozcan Erel
    Pediatric Research, 2022, 92 : 474 - 479
  • [47] Amino acid levels and nutritional outcomes in children with hereditary tyrosinemia type 1
    Brockett, J.
    Evans, M.
    Allender, B.
    Pandithan, D.
    MOLECULAR GENETICS AND METABOLISM, 2024, 141 : 12 - 13
  • [48] Early effect of NTBC on renal tubular dysfunction in hereditary tyrosinemia type 1
    Maiorana, A.
    Malamisura, M.
    Emma, F.
    Boenzi, S.
    Di Ciommo, V. M.
    Dionisi-Vici, C.
    MOLECULAR GENETICS AND METABOLISM, 2014, 113 (03) : 188 - 193
  • [49] Waddling gait and invalidating rickets as presenting signs of hereditary tyrosinemia type 1
    Rigante, D
    Holme, E
    Segni, G
    Stabile, A
    Caradonna, P
    BONE, 2001, 28 (05) : S119 - S119
  • [50] Evaluation of dynamic thiol/disulfide homeostasis in hereditary tyrosinemia type 1 patients
    Zeybek, Ayse Cigdem Aktuglu
    Kiykim, Ertugrul
    Neselioglu, Salim
    Iscan, Halise Zeynep
    Zubarioglu, Tanyel
    Cansever, Mehmet Serif
    Erel, Ozcan
    PEDIATRIC RESEARCH, 2022, 92 (02) : 474 - 479